Not applicableStudy completedNCT06752941What this trial is testingLOW-PV ContinuationWho this might be right forPolycythemia Vera FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS 36
Testing effectiveness (Phase 2)Study completedNCT02742324What this trial is testingTrial Ruxolitinib and Peg-interferon Alpha-2a Combination in Patients With Primary Myelofibrosis RUXOPegWho this might be right forMyelofibrosis French Innovative Leukemia Organisation 37
Not applicableLooking for participantsNCT02760238What this trial is testingMyeloproliferative Neoplasms (MPNs) Patient RegistryWho this might be right forPrimary MyelofibrosisPolycythemia VeraEssential Thrombocythemia+7 more University Health Network, Toronto 5,000
Early research (Phase 1)Study completedNCT00073944What this trial is testingBCX-1777 in Treating Patients With Refractory CancerWho this might be right forCancer BioCryst Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT02218047What this trial is testingAOP2014 vs. BAT in Patients With Polycythemia Vera Who Previously Participated in the PROUD-PV Study.Who this might be right forPolycythemia Vera AOP Orphan Pharmaceuticals AG 170
Not applicableLooking for participantsNCT06506084What this trial is testingObservational Study on the Use of Ropeginterferon Alfa-2b in Polycythemia Vera (ROPEG-PV)Who this might be right forPolycythemia Vera FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS 429
Testing effectiveness (Phase 2)UnknownNCT04878003What this trial is testingStudy of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve MyelofibrosisWho this might be right forPrimary Myelofibrosis (PMF)Post-Polycythemia Vera Myelofibrosis (Post-PV-MF)Post-Essential Thrombocythemia Myelofibrosis (Post-ET-MF) Kartos Therapeutics, Inc. 52
Testing effectiveness (Phase 2)Study completedNCT00823524What this trial is testingDonor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced CancerWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more Asan Medical Center 47
Early research (Phase 1)Study completedNCT00807677What this trial is testingDose Escalation Study of TAK-901 in Subjects With Advanced Hematologic MalignanciesWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+9 more Millennium Pharmaceuticals, Inc. 31
Early research (Phase 1)Study completedNCT00042900What this trial is testingPyroxamide in Treating Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT05835466What this trial is testingReparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)Who this might be right forMyelofibrosis (PMF)Post Essential Thrombocythemia Myelofibrosis (ET-MF)Post Polycythemia Vera Related Myelofibrosis (PV-MF) Icahn School of Medicine at Mount Sinai 10
Early research (Phase 1)Study completedNCT01134120What this trial is testingA Study in Myeloproliferative DisordersWho this might be right forMyeloproliferative DisordersThrombocythemia, EssentialPolycythemia Vera+1 more Eli Lilly and Company 80
Testing effectiveness (Phase 2)Study completedNCT00005622What this trial is testingDonor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic DisordersWho this might be right forChronic Myeloproliferative DisordersLeukemiaMultiple Myeloma and Malignant Plasma Cell Neoplasms+2 more H. Lee Moffitt Cancer Center and Research Institute 72
Testing effectiveness (Phase 2)Study completedNCT00430066What this trial is testingEffects of Imatinib Mesylate in Polycythemia VeraWho this might be right forPolycythemia Vera Niguarda Hospital 9
Testing effectiveness (Phase 2)Study completedNCT01901432What this trial is testingA Two-part Study to Assess the Safety and Preliminary Efficacy of Givinostat in Patients With Polycythemia VeraWho this might be right forPolycythemia Vera Italfarmaco 48
Large-scale testing (Phase 3)Study completedNCT01243944What this trial is testingStudy of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 (INCB018424) Tablets Versus Best Available Care: (The RESPONSE Trial)Who this might be right forPolycythemia Vera Incyte Corporation 222
Testing effectiveness (Phase 2)Looking for participantsNCT06770842What this trial is testingRopeginterferon Alfa 2b Plus Ruxolitinib for MyelofibrosisWho this might be right forPrimary Myelofibrosis (PMF)Post Polycythemia Myelofibrosis (PPV MF)Post Essential Thrombocythaemia Myelofibrosis (PET-MF) The University of Hong Kong 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05499013What this trial is testingStudy to Assess SLN124 in Patients With Polycythemia VeraWho this might be right forPolycythemia Vera Silence Therapeutics plc 69
Testing effectiveness (Phase 2)Study completedNCT00006379What this trial is testingNon-Ablative Allo HSCT For Hematologic Malignancies or SAAWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more Case Comprehensive Cancer Center 58
Not applicableWithdrawnNCT02663648What this trial is testingCell Cycle Regulatory Gene Study in Patients With Myeloproliferative DisordersWho this might be right forMyeloproliferative DisordersPolycythemia VeraEssential Thrombocythemia+2 more Shandong University